Sai Life Sciences IPO Subscription Status
Sai Life Sciences IPO was subscribed 10.27 times when bidding closed on 13 Dec 2024: QIB 29.78x, NII 4.99x, Retail 1.39x.
The Sai Life Sciences IPO has been subscribed 10.27x times overall. Retail investors have shown interest with bids for 1.39x the shares available. The Non-Institutional Investor (NII) category has been subscribed 4.99x. Within NII, Big HNI (B-HNI) subscribed 6.1x and Small HNI (S-HNI) subscribed 2.78x. Qualified Institutional Buyers (QIBs) have subscribed 29.78x. Data last updated on 10 Nov, 11:34 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 11 Dec, 2024 and closes on 13 Dec, 2024. The shares are expected to list on stock exchanges on 18 Dec, 2024.
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 29.78x |
| NII | - of - - | 4.99x |
bHNI — bid amount above ₹10 Lakh |
- - | 6.1 |
sHNI — bid amount ₹2–10 Lakh |
- - | 2.78 |
| Retail | - of - - | 1.39x |
| TOTAL | - - | 10.27x |
Sai Life Sciences IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 71.9% for a single lot.
Institutional Backing
Massive institutional interest with QIBs subscribing 29.78x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
13 Dec 2024
Day 3 |
10.27x | ▼ | |
|
QIB29.78x
BHNI6.1x
SHNI2.78x
Retail1.39x
|
|||
|
12 Dec 2024
Day 2 |
1.25x | ▼ | |
|
QIB3.32x
BHNI0.58x
SHNI0.62x
Retail0.42x
|
|||
|
11 Dec 2024
Day 1 |
0.84x | ▼ | |
|
QIB2.62x
BHNI0.15x
SHNI0.17x
Retail0.18x
|
|||
Sai Life Sciences IPO dates
From the bidding window to listing. Today is 14 November.
- Open 11 Dec 2024
- Close 13 Dec 2024
- Allotment 16 Dec 2024
- Refund/credit 17 Dec 2024
- Listing 18 Dec 2024
Anchor investor allocation
Shares allotted to anchor investors the working day before the issue opened.
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Sai Life Sciences IPO?
As of IPO close date (13 Dec, 2024), the Sai Life Sciences IPO is subscribed 10.27x times. Retail category is 1.39x, and NII is 4.99x subscribed.
When is the allotment date for Sai Life Sciences IPO?
The allotment for Sai Life Sciences IPO is expected to be finalized on 16 December, 2024.
What is the GMP of Sai Life Sciences?
The Grey Market Premium (GMP) for Sai Life Sciences is currently ₹70, indicating a potential listing gain of 13%.
When will Sai Life Sciences IPO list on the stock market?
Sai Life Sciences is scheduled to list on BSE and NSE on 18 December, 2024.
What are the chances of getting allotment in Sai Life Sciences IPO?
The retail category is oversubscribed at 1.39x, meaning allotment is by lottery. Statistically, approximately 1 in 2 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 29.78x mean for Sai Life Sciences IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 29.78x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Sai Life Sciences IPO allotment status?
After the allotment date (16 Dec, 2024), you can check your Sai Life Sciences IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Sai Life Sciences IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.